Literature DB >> 23484808

Knockdown of phospholipase C-epsilon by short-hairpin RNA-mediated gene silencing induces apoptosis in human bladder cancer cell lines.

Yanyi Zhang1, Ling Yan, Yi Zhao, Liping Ou, Xiaohou Wu, Chunli Luo.   

Abstract

Transitional cell carcinoma of bladder (TCCB) is a common malignancy worldwide, and outcomes for patients with advanced bladder cancer remain poor. To study the pathogenesis of TCCB, we investigated roles of Phospholipase C (PLC)ɛ, an effector of Ras and Rap small GTPases. RNA interference was used to knockdown PLCɛ expression in human bladder cancer cell lines (BIU-87 and T24). The expression levels of PLCɛ mRNA and protein were detected by reverse transcriptase-polymerase chain reaction and Western blot, respectively. Flow cytometry (FCM) was used to detect distribution of cell cycle. Cellular apoptosis was reflected by transmission electron microscopy and the expression of bcl-2 and bax. We found that PLCɛ could be efficiently knocked down by shRNA. FCM assay showed that the pGenesil-PLCɛ-transfected cells were arrested at the G0/G1 phase. Silence of PLCɛ might induce apoptosis via modulation of bcl-2 and bax. In conclusion, our results suggest that PLCɛ plays an important role in the pathogenesis of human bladder cancer cells. PLCɛ may be used as a potential target of gene therapy for bladder cancer in future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23484808     DOI: 10.1089/cbr.2012.1216

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  7 in total

1.  Knockdown of PLCε inhibits inflammatory cytokine release via STAT3 phosphorylation in human bladder cancer cells.

Authors:  Xue Yang; Liping Ou; Min Tang; Yin Wang; Xiaorong Wang; E Chen; Jianjun Diao; Xiaohou Wu; Chunli Luo
Journal:  Tumour Biol       Date:  2015-07-09

Review 2.  PLCε signaling in cancer.

Authors:  Rui-Yan Zhang; Wen-Qi Du; Ying-Chun Zhang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-25       Impact factor: 4.553

3.  Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.

Authors:  Daiane Teixeira DE Oliveira; Andre Luiz Ventura Savio; Joao Paulo DE Castro Marcondes; Tatiane Martins Barros; Ludmila Correia Barbosa; Daisy Maria Favero Salvadori; Glenda Nicioli DA Silva
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

4.  Phospholipase C ε-1 gene polymorphisms and prognosis of esophageal cancer patients from a high-incidence region in northern China.

Authors:  Rong-Miao Zhou; Yan Li; Na Wang; Xi Huang; Shi-Ru Cao
Journal:  Mol Clin Oncol       Date:  2017-10-27

5.  Comprehensive bioinformatics analysis of the mRNA profile of PLCE1 knockdown in esophageal squamous cell carcinoma.

Authors:  Xiaobin Cui; Huahua Xin; Hao Peng; Yunzhao Chen
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

6.  Inhibition of the Phospholipase Cε-c-Jun N-Terminal Kinase Axis Suppresses Glioma Stem Cell Properties.

Authors:  Masashi Okada; Yurika Nakagawa-Saito; Yuta Mitobe; Asuka Sugai; Keita Togashi; Shuhei Suzuki; Chifumi Kitanaka
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

7.  U-73122 reduces the cell growth in cultured MG-63 ostesarcoma cell line involving Phosphoinositide-specific Phospholipases C.

Authors:  Vincenza Rita Lo Vasco; Martina Leopizzi; Valeria Di Maio; Carlo Della Rocca
Journal:  Springerplus       Date:  2016-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.